You are here: Home > Therapeutics (former) > Therapeutic Cannabis (Marijuana) as an Antiemetic and Appetite Stimulant in Persons with Acquired Immunodeficiency Syndrome (AIDS)

J Cannabis Ther 2001(3/4):005-16

Antiemetic and Appetite Stimulant

Therapeutic Cannabis (Marijuana) as an Antiemetic and Appetite Stimulant in Persons with Acquired Immunodeficiency Syndrome (AIDS)

Author
R.E. Bayer

Abstract
Acquired immunodeficiency syndrome (AIDS) is a common cause of death among young adults in the USA. AIDS wasting syndrome is the most common clinical presentation of AIDS. Antiretroviral drug therapy has improved the prognosis of persons with AIDS, but also contributed side effects, particularly nausea and anorexia. Case reports demonstrate persons with AIDS use cannabis as medicine to control nausea, anorexia, and pain, while noting improved mood. Recent clinical research comparing smoked cannabis to oral dronabinol (synthetic THC or Marinol ) demonstrates no immune dysfunction in persons using cannabinoids and positive weight gain when cannabinoids are compared to placebo. Harm reduction research indicates that heating cannabis to temperatures well below combustion ("vaporization") yields active cannabinoids and a significant reduction or elimination of toxics (benzene, toluene, naphthalene, carbon monoxide, and tars) commonly found in smoked cannabis. More research is indicated but vaporizers appear to substantially reduce what is widely perceived as the leading health risk of cannabis, namely respiratory damage from smoking. In spite of a need for more rigorous scientifically controlled research, an increasing number of persons with AIDS are using cannabis to control nausea, increase appetite, promote weight gain, decrease pain, and improve mood.


Keywords
Cannabis, marijuana, dronabinol, THC, Marinol , AIDS, HIV, harm reduction, immunodeficiency, vaporization, vaporizer, wasting, anorexia, nausea, appetite, pain

PDF of the full text ]

Free Online Events 2020

You can find all information here.

The IACM is holding a free webinar series and a free anniversary online meeting from October to November 2020

All webinars will be held in English with subtitles in German, French, Spanish, and Portuguese. All webinars will be available online until March 2021

The anniversary online meeting to celebrate the IACM's 20th anniversary and to honour the 90th birthday of Raphael Mechoulam will be a live session only on the 5th November 2020.

The speakers in the webinar series are Donald I. Abrams, Bonni Goldstein, Franjo Grotenhermen, Manuel Guzmán, Raphael Mechoulam, Kirsten Müller-Vahl, Roger Pertwee, Daniele Piomelli, and Ethan Russo.

You can find all information here.
 

IACM Conference 2021

The 12th IACM Conference on Cannabinoids in Medicine will be held in Basel, Switzerland, from 14 to 16 October 2021.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.